RU +7 (495) 747 11 17

The clinical researches of Endofortis APPLICATION SCOPE

According to the state registration certificate, Endofortis contributes to the antiviral effect of indirect action due to endogenous immunomodulation and interferonogenic activities. Endofortis is a plant-based inducer of IL-12 and IFN-gamma, helps to protect the body from virus infections when they penetrate the mucous membranes, as well as after virus replication into cells.

The clinical researches of Endofortis

DUE TO THE UNIQUE COMPONENT COMPOSITION, ENDOFORTIS PROMOTES:

The clinical researches of Endofortis the body protection from ARVI viruses and coronavirus infection both before and after they enter the body,

The clinical researches of Endofortis gentle stimulation of one’s own antiviral immunity, which is involved in infection combatting regardless of its strain,

The clinical researches of Endofortis the suppression of inflammatory processes at the cellular level,

The clinical researches of Endofortis combating the consequences of covid.

Also, component composition of Endofortis has the following effects:
anti-inflammatory, immunomodulatory, antioxidant, antimicrobal, anticoagulant, antihypertensive, neuroprotective.

The clinical researches of Endofortis POST-COVID-19 SYNDROME

The clinical researches of Endofortis

The symptoms of acute COVID-19 are well described in numerous studies. They are characterized by lesions of the respiratory and nervous system, gastrointestinal tract, and, less frequently, skin and mucous membranes.

In the case of severe COVID-19, the development of pneumonia, acute respiratory distress syndrome, multiple organ failure, sepsis and disseminated vascular coagulation syndrome is reported.

Studies show that up to half of patients, who have had the disease even in its mild form, experience long-term effects. Their spectrum goes beyond respiratory complications and affects many organs and systems.

The severity of symptoms ranges from mild discomfort to serious adverse effects on physical, cognitive and psychosocial health. The most common symptoms were impaired attention and memory, depression, anxiety, labored breathing, cough, weakness and fatigue. Manifestations from the cardiovascular system, gastrointestinal tract, and skin and ENT organs were also reported.

The clinical researches of EndofortisWHY THIS HAPPENS?

Coronavirus can stay in the body and persist for up to 7 months. It continues to damage body cells, including neurons. It also keeps inflammatory processes highly active.

The clinical researches of EndofortisThis is confirmed by WHO data

3.92 billion people had Covid, of which:

  • The clinical researches of Endofortis 144 million had developed post-Covid-19 syndrome
  • The clinical researches of Endofortis 22 million still had symptoms 12 months after infection

At the California Research Institute, 60% of patients with “long COVID-19” with duration of 12 months after diagnosis were reported to have SARS-CoV-2 spike antigen in their blood.

The clinical researches of Endofortis

ENDOFORTIS IN POST-COVID-19 SYNDROME:

The clinical researches of Endofortis composition is made up of herbal ingredients, each carefully studied
precisely adjusted proportions

The clinical researches of Endofortis safe combination

The clinical researches of Endofortis each component individually and the combination as a whole, helps the body to cope with consequences of Covid-19.

CLINICAL RESEARCH OF ENDOFORTIS

Clinical researches in November-December 2022 included patients of different ages.

They were united by one problem — post-Covid-19 syndrome. They suffered from labored breathing, severe weakness and other unpleasant symptoms while recovering from Covid-19. They received Endofortis 2 capsules 2 times daily for one month.

During the research, all patients significant improved their test results and general physical and psychological well-being:

The clinical researches of Endofortis

The clinical researches of Endofortis25% of patients completely got rid of labored breathing, and in the remaining 75%, in dynamics it significantly decreased with a tendency to further reduction;

The clinical researches of EndofortisIn 100% of patients, blood oxygen saturation levels increased to normal levels of 97%.

  • The clinical researches of Endofortis The rates of acute inflammation and cell damage C-reactive protein and LDH decreased;
  • The clinical researches of Endofortis ESR level decreased within the reference values;
  • The clinical researches of Endofortis The quality of life of patients increased by 39% based on the results of completion of the questionnaire.

Patients were carefully examined both before and after the study. There were no any adverse effects. All important parameters also remained normal: general blood count, blood pressure, body temperature, pulse rate, respiratory rate.

The clinical researches of Endofortis

SCIENTIFIC RESEARCH OF ENDOFORTIS COMPONENTS

Endofortis is a unique combination of natural ingredients, each with proven properties. Below are active links to independent scientific studies on each component.

In case of coronavirus consequences, it is important to activate the body’s own forces to fight the virus and the late consequences. Endofortis acts comprehensively and gently. It acts specifically on the links of immunity, which are responsible for combatting viral infections. It helps people with post-Covid-19 syndrome to restore health and return to their normal life.

The clinical researches of EndofortisClinical research of Endofortis preparation. The results of the clinical research of the dietary supplement Endofortis and independent scientific researches of the properties of the components confirm its effectiveness in treating viral diseases and post-Covid-19 syndrome.

Lysenko Marina Nikolaevna
Cardiologist at the N.V. Sklifosovsky Research Institute of Emergency Medicine, therapist of the highest category with work experience.

SUBSCRIBE TO OUR NEWS